Article Details
Retrieved on: 2021-04-15 19:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... front-line trials comparing Bruton's tyrosine kinase (BTK) inhibitors and BCL2 inhibitors, with or without CD20 monoclonal antibodies, are warranted.
Article found on: www.pharmacytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here